BrightSpring Health Services, Inc. (BTSG)
NASDAQ: BTSG · Real-Time Price · USD
72.86
+0.24 (0.33%)
Nov 12, 2026, 12:07 PM EST - Market open
BTSG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15,251 | 12,911 | 10,072 | 7,691 | 7,721 | 6,698 | |
Revenue Growth | 25.97% | 28.18% | 30.96% | -0.38% | 15.27% | 20.03% |
Cost of Revenue | 13,345 | 11,393 | 8,806 | 6,552 | 6,366 | 5,450 |
Gross Profit | 1,906 | 1,518 | 1,266 | 1,139 | 1,354 | 1,248 |
Selling, General & Admin | 1,371 | 1,195 | 1,102 | 1,070 | 1,148 | 1,023 |
Operating Expenses | 1,371 | 1,195 | 1,102 | 1,070 | 1,148 | 1,027 |
Operating Income | 535.46 | 322.38 | 164.32 | 68.62 | 206.29 | 221.38 |
Interest Expense | -145.07 | -157.31 | -190.55 | -271.9 | -233.58 | -165.32 |
Other Non Operating Income (Expenses) | - | - | -27.08 | -8 | -4.9 | -4.1 |
EBT Excluding Unusual Items | 390.39 | 165.07 | -53.31 | -211.28 | -32.2 | 51.96 |
Merger & Restructuring Charges | -2.4 | -14.5 | -3.4 | - | - | - |
Impairment of Goodwill | - | - | - | - | -40.86 | - |
Asset Writedown | -12.63 | -12.63 | -4 | -2.5 | -2.5 | -3.4 |
Legal Settlements | - | - | -21.89 | - | - | - |
Other Unusual Items | - | - | -12.73 | - | 29.8 | 20.3 |
Pretax Income | 375.37 | 137.94 | -95.32 | -213.77 | -45.75 | 68.86 |
Income Tax Expense | 64.13 | 33.15 | -26.39 | -31.51 | 8.47 | 17.6 |
Earnings From Continuing Operations | 311.24 | 104.8 | -68.93 | -182.27 | -54.22 | 51.26 |
Earnings From Discontinued Operations | 99.2 | 84.32 | 48.41 | 25.43 | - | - |
Net Income to Company | 410.44 | 189.11 | -20.52 | -156.84 | -54.22 | 51.26 |
Minority Interest in Earnings | -0.16 | 1.55 | 2.46 | 2.23 | 0.31 | -1.46 |
Net Income | 410.28 | 190.67 | -18.06 | -154.6 | -53.91 | 49.8 |
Net Income to Common | 410.28 | 190.67 | -18.06 | -154.6 | -53.91 | 49.8 |
Net Income Growth | 216.61% | - | - | - | - | 139.30% |
Shares Outstanding (Basic) | 205 | 203 | 193 | 118 | 118 | 118 |
Shares Outstanding (Diluted) | 222 | 220 | 193 | 118 | 118 | 122 |
Shares Change | 3.57% | 13.87% | 63.74% | 0.02% | -3.24% | 3.53% |
EPS (Basic) | 2.00 | 0.94 | -0.09 | -1.31 | -0.46 | 0.42 |
EPS (Diluted) | 1.84 | 0.86 | -0.09 | -1.31 | -0.46 | 0.41 |
EPS Growth | 204.99% | - | - | - | - | 130.54% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 492.41 | 394.69 | -57.14 | 137.26 | -74.77 | 210.9 |
Free Cash Flow Per Share | 2.22 | 1.80 | -0.30 | 1.16 | -0.63 | 1.73 |
Gross Margin | 12.50% | 11.76% | 12.57% | 14.81% | 17.54% | 18.63% |
Operating Margin | 3.51% | 2.50% | 1.63% | 0.89% | 2.67% | 3.31% |
Profit Margin | 2.69% | 1.48% | -0.18% | -2.01% | -0.70% | 0.74% |
Free Cash Flow Margin | 3.23% | 3.06% | -0.57% | 1.79% | -0.97% | 3.15% |
EBITDA | 693.87 | 485.33 | 326.46 | 229.18 | 410.26 | 420.54 |
EBITDA Margin | 4.55% | 3.76% | 3.24% | 2.98% | 5.31% | 6.28% |
D&A For EBITDA | 158.41 | 162.95 | 162.14 | 160.56 | 203.97 | 199.16 |
EBIT | 535.46 | 322.38 | 164.32 | 68.62 | 206.29 | 221.38 |
EBIT Margin | 3.51% | 2.50% | 1.63% | 0.89% | 2.67% | 3.31% |
Effective Tax Rate | 17.08% | 24.03% | - | - | - | 25.56% |
Revenue as Reported | 15,251 | 12,911 | 10,072 | 7,691 | 7,721 | 6,698 |